| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibronectins | 7 | 2009 | 208 | 1.260 |
Why?
|
| Monocytes | 12 | 2009 | 790 | 1.210 |
Why?
|
| HIV-1 | 9 | 2009 | 641 | 0.960 |
Why?
|
| Peptide Fragments | 5 | 2009 | 1316 | 0.710 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2004 | 717 | 0.640 |
Why?
|
| HIV Infections | 9 | 2009 | 2158 | 0.640 |
Why?
|
| Endothelium, Vascular | 8 | 2004 | 884 | 0.580 |
Why?
|
| Antigen-Antibody Complex | 15 | 1995 | 125 | 0.530 |
Why?
|
| Complement C1 | 7 | 1994 | 14 | 0.450 |
Why?
|
| Integrin alpha5 | 2 | 2009 | 13 | 0.410 |
Why?
|
| Lymphocyte Activation | 10 | 2019 | 1722 | 0.380 |
Why?
|
| Lymph | 11 | 2001 | 70 | 0.380 |
Why?
|
| Myocardial Reperfusion | 6 | 1997 | 102 | 0.350 |
Why?
|
| Myocardial Ischemia | 6 | 2004 | 428 | 0.340 |
Why?
|
| Chemotaxis, Leukocyte | 6 | 2014 | 161 | 0.340 |
Why?
|
| Complement Activation | 5 | 2014 | 94 | 0.330 |
Why?
|
| Complement Activating Enzymes | 6 | 1989 | 12 | 0.330 |
Why?
|
| Phagocytosis | 5 | 2004 | 293 | 0.290 |
Why?
|
| Neutrophils | 11 | 2001 | 875 | 0.290 |
Why?
|
| Cell Movement | 8 | 2002 | 2484 | 0.280 |
Why?
|
| Computer-Assisted Instruction | 1 | 2007 | 88 | 0.270 |
Why?
|
| Antibodies, Anti-Idiotypic | 8 | 1984 | 101 | 0.270 |
Why?
|
| Emphysema | 2 | 2019 | 88 | 0.270 |
Why?
|
| Complement C1q | 7 | 2019 | 29 | 0.260 |
Why?
|
| Lymphocytes | 14 | 2002 | 1279 | 0.260 |
Why?
|
| Asthma | 2 | 2018 | 895 | 0.250 |
Why?
|
| Complement C5a | 2 | 1997 | 35 | 0.250 |
Why?
|
| Immunoglobulin G | 18 | 2013 | 1139 | 0.250 |
Why?
|
| CD3 Complex | 1 | 2005 | 320 | 0.240 |
Why?
|
| Coronary Disease | 8 | 1992 | 774 | 0.240 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1997 | 370 | 0.220 |
Why?
|
| Dogs | 14 | 2001 | 1168 | 0.220 |
Why?
|
| Myocardium | 9 | 1997 | 1233 | 0.210 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 745 | 0.200 |
Why?
|
| Receptors, Complement | 3 | 2014 | 48 | 0.200 |
Why?
|
| Mitochondria, Heart | 2 | 1994 | 77 | 0.200 |
Why?
|
| Immunoglobulin M | 13 | 2013 | 361 | 0.190 |
Why?
|
| Antibodies, Bacterial | 2 | 2011 | 418 | 0.190 |
Why?
|
| Antigens, CD | 5 | 2004 | 1429 | 0.180 |
Why?
|
| Antibody Formation | 16 | 1995 | 386 | 0.180 |
Why?
|
| Immunoglobulin Fab Fragments | 4 | 1984 | 93 | 0.180 |
Why?
|
| Receptors, Fibronectin | 1 | 1999 | 26 | 0.170 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2009 | 309 | 0.170 |
Why?
|
| Chemokine CCL2 | 2 | 1997 | 200 | 0.170 |
Why?
|
| Cocaine-Related Disorders | 2 | 2013 | 239 | 0.160 |
Why?
|
| Leukocytes | 5 | 1997 | 425 | 0.160 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 287 | 0.150 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 101 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 4 | 1984 | 498 | 0.150 |
Why?
|
| Th17 Cells | 1 | 2019 | 163 | 0.150 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 1997 | 73 | 0.140 |
Why?
|
| Lung Diseases, Fungal | 1 | 2018 | 133 | 0.140 |
Why?
|
| Cystic Fibrosis | 2 | 1990 | 295 | 0.140 |
Why?
|
| HLA Antigens | 4 | 1995 | 594 | 0.140 |
Why?
|
| Cell Adhesion | 7 | 2004 | 1035 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 2 | 1997 | 458 | 0.130 |
Why?
|
| Reperfusion Injury | 2 | 1998 | 152 | 0.130 |
Why?
|
| Bronchodilator Agents | 1 | 2018 | 225 | 0.130 |
Why?
|
| Bartonella | 1 | 1995 | 13 | 0.130 |
Why?
|
| Immunologic Surveillance | 1 | 1995 | 60 | 0.120 |
Why?
|
| Cardiolipins | 1 | 1994 | 33 | 0.120 |
Why?
|
| Reactive Oxygen Species | 3 | 1995 | 1008 | 0.120 |
Why?
|
| Coronary Vessels | 3 | 1997 | 632 | 0.120 |
Why?
|
| Flow Cytometry | 6 | 2004 | 3073 | 0.110 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1994 | 55 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2005 | 3942 | 0.110 |
Why?
|
| Antibody Specificity | 4 | 2013 | 340 | 0.110 |
Why?
|
| Cholera Vaccines | 1 | 2013 | 4 | 0.110 |
Why?
|
| Measles virus | 1 | 1993 | 17 | 0.110 |
Why?
|
| Cholera Toxin | 1 | 2013 | 69 | 0.110 |
Why?
|
| Humans | 78 | 2019 | 271550 | 0.110 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 1104 | 0.110 |
Why?
|
| Measles | 1 | 1993 | 38 | 0.110 |
Why?
|
| Rabbits | 8 | 1995 | 1074 | 0.110 |
Why?
|
| Glomerulonephritis | 3 | 1979 | 123 | 0.100 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2001 | 181 | 0.100 |
Why?
|
| Immune Tolerance | 3 | 2019 | 427 | 0.100 |
Why?
|
| Macrophages | 4 | 2004 | 1360 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2018 | 876 | 0.100 |
Why?
|
| CD18 Antigens | 5 | 1998 | 86 | 0.100 |
Why?
|
| Complement System Proteins | 5 | 1995 | 134 | 0.100 |
Why?
|
| Integrins | 2 | 1993 | 278 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 1121 | 0.100 |
Why?
|
| Immunoglobulin A | 5 | 1989 | 274 | 0.090 |
Why?
|
| Cocaine | 1 | 2013 | 244 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 4153 | 0.090 |
Why?
|
| Arthritis, Juvenile | 2 | 1982 | 58 | 0.090 |
Why?
|
| gamma-Globulins | 10 | 1970 | 19 | 0.090 |
Why?
|
| Pancreatic Elastase | 1 | 1990 | 35 | 0.090 |
Why?
|
| Hypergammaglobulinemia | 1 | 1989 | 23 | 0.090 |
Why?
|
| Collagen Type II | 1 | 2010 | 38 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1997 | 840 | 0.090 |
Why?
|
| Male | 44 | 2019 | 128724 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2010 | 64 | 0.090 |
Why?
|
| Antibodies | 12 | 1994 | 816 | 0.080 |
Why?
|
| Hyaluronan Receptors | 2 | 1988 | 249 | 0.080 |
Why?
|
| Immunotherapy, Active | 1 | 2009 | 49 | 0.080 |
Why?
|
| Complement Pathway, Classical | 1 | 1989 | 8 | 0.080 |
Why?
|
| Animals | 30 | 2019 | 62359 | 0.080 |
Why?
|
| Pneumococcal Vaccines | 1 | 2011 | 184 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2009 | 296 | 0.080 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 153 | 0.080 |
Why?
|
| Pulmonary Alveoli | 1 | 1990 | 223 | 0.080 |
Why?
|
| Methadone | 1 | 2009 | 211 | 0.070 |
Why?
|
| Pokeweed Mitogens | 2 | 1984 | 13 | 0.070 |
Why?
|
| Viral Load | 1 | 2009 | 482 | 0.070 |
Why?
|
| Extracellular Matrix | 2 | 2001 | 530 | 0.070 |
Why?
|
| Adult | 30 | 2019 | 82003 | 0.070 |
Why?
|
| HLA-DR Antigens | 2 | 2004 | 184 | 0.070 |
Why?
|
| Mucus | 7 | 1970 | 109 | 0.070 |
Why?
|
| Leucine | 2 | 2005 | 379 | 0.070 |
Why?
|
| Computers | 1 | 2007 | 140 | 0.070 |
Why?
|
| Osteoarthritis, Knee | 1 | 2010 | 193 | 0.070 |
Why?
|
| Cells, Cultured | 8 | 2019 | 5740 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 1992 | 579 | 0.070 |
Why?
|
| Cytotoxins | 3 | 1983 | 65 | 0.070 |
Why?
|
| Cause of Death | 1 | 2009 | 784 | 0.070 |
Why?
|
| Phagocytes | 2 | 1997 | 43 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2004 | 1590 | 0.070 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 1984 | 52 | 0.060 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2005 | 90 | 0.060 |
Why?
|
| Smoking | 1 | 2014 | 2549 | 0.060 |
Why?
|
| CD11 Antigens | 3 | 1998 | 23 | 0.060 |
Why?
|
| In Vitro Techniques | 4 | 1999 | 1728 | 0.060 |
Why?
|
| Growth Substances | 1 | 1985 | 328 | 0.060 |
Why?
|
| Lymphokines | 1 | 1985 | 315 | 0.060 |
Why?
|
| B7-2 Antigen | 1 | 2004 | 53 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2009 | 519 | 0.060 |
Why?
|
| L-Selectin | 1 | 2004 | 36 | 0.060 |
Why?
|
| CD11b Antigen | 1 | 2004 | 64 | 0.060 |
Why?
|
| Myeloblastin | 1 | 2004 | 65 | 0.060 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2004 | 115 | 0.060 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2004 | 59 | 0.060 |
Why?
|
| Hemocyanins | 1 | 1983 | 54 | 0.060 |
Why?
|
| Immunoglobulins | 4 | 1979 | 289 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2009 | 3610 | 0.060 |
Why?
|
| Coronary Circulation | 3 | 1997 | 249 | 0.060 |
Why?
|
| Neurons | 1 | 1994 | 2458 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 278 | 0.050 |
Why?
|
| Sputum | 2 | 2018 | 159 | 0.050 |
Why?
|
| Leukocyte Count | 3 | 2018 | 737 | 0.050 |
Why?
|
| Female | 27 | 2019 | 149106 | 0.050 |
Why?
|
| Streptodornase and Streptokinase | 1 | 1982 | 2 | 0.050 |
Why?
|
| Serum Albumin | 7 | 1985 | 246 | 0.050 |
Why?
|
| Staphylococcal Protein A | 1 | 1981 | 16 | 0.050 |
Why?
|
| Immune Complex Diseases | 2 | 1979 | 13 | 0.050 |
Why?
|
| Prognosis | 9 | 2009 | 22524 | 0.050 |
Why?
|
| Middle Aged | 15 | 2019 | 90422 | 0.050 |
Why?
|
| Complement C3 | 3 | 2014 | 81 | 0.050 |
Why?
|
| Antigens | 5 | 1971 | 283 | 0.050 |
Why?
|
| Heart Ventricles | 2 | 1997 | 848 | 0.040 |
Why?
|
| Time Factors | 8 | 1998 | 13077 | 0.040 |
Why?
|
| Cell Line | 5 | 1994 | 5373 | 0.040 |
Why?
|
| Cell Survival | 3 | 2004 | 3068 | 0.040 |
Why?
|
| Transplantation Immunology | 5 | 1974 | 107 | 0.040 |
Why?
|
| Software | 1 | 2007 | 1392 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2001 | 351 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2004 | 1731 | 0.040 |
Why?
|
| Lung | 4 | 2019 | 3300 | 0.040 |
Why?
|
| Periodontal Diseases | 1 | 1979 | 23 | 0.040 |
Why?
|
| Adolescent | 8 | 2009 | 32726 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 1985 | 1427 | 0.040 |
Why?
|
| Aged | 10 | 2019 | 73451 | 0.040 |
Why?
|
| Smoke | 1 | 2019 | 61 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 701 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2002 | 729 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 2659 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 203 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 1505 | 0.040 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2018 | 24 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1989 | 725 | 0.040 |
Why?
|
| Microcirculation | 1 | 1998 | 194 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2004 | 1109 | 0.040 |
Why?
|
| Cytokines | 2 | 1998 | 2825 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 5082 | 0.040 |
Why?
|
| Immunity, Cellular | 5 | 1989 | 442 | 0.040 |
Why?
|
| Tobacco Products | 1 | 2019 | 153 | 0.040 |
Why?
|
| Integrin alpha4 | 1 | 1997 | 26 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 8 | 1975 | 1138 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2019 | 631 | 0.040 |
Why?
|
| Sarcolemma | 2 | 1994 | 31 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2019 | 267 | 0.040 |
Why?
|
| Protein Binding | 3 | 1994 | 3497 | 0.040 |
Why?
|
| Ultracentrifugation | 8 | 1983 | 40 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 759 | 0.040 |
Why?
|
| Respiratory System | 1 | 2018 | 130 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2019 | 5750 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2007 | 17039 | 0.040 |
Why?
|
| Eosinophils | 1 | 2018 | 166 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 1998 | 230 | 0.030 |
Why?
|
| Extracellular Space | 1 | 1997 | 148 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 1997 | 131 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 2 | 1989 | 4139 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1999 | 6706 | 0.030 |
Why?
|
| Immune Sera | 5 | 1992 | 145 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1081 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 1989 | 5606 | 0.030 |
Why?
|
| Chemotactic Factors | 2 | 1992 | 42 | 0.030 |
Why?
|
| Child | 6 | 2007 | 30545 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 4582 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 1 | 1995 | 27 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 1995 | 22 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2013 | 2588 | 0.030 |
Why?
|
| Proteus Infections | 1 | 1975 | 8 | 0.030 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2014 | 18 | 0.030 |
Why?
|
| Complement C3a | 1 | 2014 | 21 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 1984 | 329 | 0.030 |
Why?
|
| Urease | 1 | 1975 | 78 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1994 | 8 | 0.030 |
Why?
|
| Phospholipases | 1 | 1994 | 13 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 44 | 0.030 |
Why?
|
| Pyelonephritis | 1 | 1975 | 48 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 714 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2014 | 88 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 2014 | 71 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1994 | 62 | 0.030 |
Why?
|
| Immunoelectrophoresis | 8 | 1975 | 27 | 0.030 |
Why?
|
| Kinetics | 3 | 1992 | 2228 | 0.030 |
Why?
|
| HIV Core Protein p24 | 1 | 1994 | 18 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 1994 | 31 | 0.030 |
Why?
|
| Quinolinic Acid | 1 | 1994 | 23 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2014 | 128 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 7 | 1981 | 158 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 7404 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 2096 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1990 | 731 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 1994 | 121 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 1993 | 62 | 0.030 |
Why?
|
| Antilymphocyte Serum | 2 | 1971 | 237 | 0.030 |
Why?
|
| Phenotype | 2 | 1995 | 6493 | 0.030 |
Why?
|
| Immunochemistry | 1 | 1992 | 61 | 0.030 |
Why?
|
| Reaction Time | 1 | 1994 | 238 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 2 | 1990 | 72 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1973 | 200 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 377 | 0.030 |
Why?
|
| Receptors, Leukocyte-Adhesion | 2 | 1989 | 17 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1992 | 57 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 1993 | 298 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1995 | 492 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 1975 | 455 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 1994 | 4493 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1997 | 1052 | 0.030 |
Why?
|
| Culture Media | 1 | 1993 | 348 | 0.030 |
Why?
|
| Inflammation | 3 | 2004 | 2531 | 0.030 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 1983 | 53 | 0.020 |
Why?
|
| Cell Communication | 1 | 1994 | 519 | 0.020 |
Why?
|
| Salmonella typhi | 3 | 1967 | 20 | 0.020 |
Why?
|
| Genes, MHC Class II | 2 | 1982 | 71 | 0.020 |
Why?
|
| Antigens, Differentiation | 2 | 1989 | 248 | 0.020 |
Why?
|
| Endotoxins | 3 | 1971 | 97 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 288 | 0.020 |
Why?
|
| Rhinovirus | 3 | 1970 | 67 | 0.020 |
Why?
|
| Melanoma | 4 | 1983 | 5598 | 0.020 |
Why?
|
| Precipitin Tests | 3 | 1983 | 357 | 0.020 |
Why?
|
| Aging | 1 | 1979 | 1555 | 0.020 |
Why?
|
| Dimercaprol | 1 | 1990 | 5 | 0.020 |
Why?
|
| Heart Transplantation | 4 | 1971 | 901 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1990 | 71 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 1992 | 531 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 1975 | 342 | 0.020 |
Why?
|
| HLA-DR3 Antigen | 1 | 1989 | 1 | 0.020 |
Why?
|
| HLA-DR2 Antigen | 1 | 1989 | 11 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2010 | 37 | 0.020 |
Why?
|
| Common Cold | 2 | 1967 | 35 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 1982 | 97 | 0.020 |
Why?
|
| Rheumatoid Factor | 2 | 1982 | 11 | 0.020 |
Why?
|
| Proteins | 3 | 1966 | 2050 | 0.020 |
Why?
|
| Transferrin | 2 | 1966 | 76 | 0.020 |
Why?
|
| Complement Fixation Tests | 1 | 1989 | 37 | 0.020 |
Why?
|
| Substance Abuse Detection | 1 | 2009 | 69 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 1982 | 604 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 6234 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1994 | 519 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 1992 | 1054 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1989 | 253 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1990 | 475 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1995 | 1135 | 0.020 |
Why?
|
| Parotid Gland | 2 | 1968 | 116 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1994 | 1000 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 607 | 0.020 |
Why?
|
| Nasal Polyps | 1 | 1968 | 28 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1990 | 250 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1988 | 340 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 1968 | 61 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2019 | 4157 | 0.020 |
Why?
|
| Mitochondrial Proteins | 2 | 1988 | 377 | 0.020 |
Why?
|
| Nervous System | 1 | 1989 | 183 | 0.020 |
Why?
|
| Chromatography, Gel | 6 | 1979 | 160 | 0.020 |
Why?
|
| Salivary Glands | 1 | 1968 | 140 | 0.020 |
Why?
|
| Diphtheria Toxoid | 2 | 1981 | 13 | 0.020 |
Why?
|
| Spleen | 3 | 2004 | 724 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 4380 | 0.020 |
Why?
|
| Calcium | 1 | 1993 | 1589 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5163 | 0.020 |
Why?
|
| Kidney Glomerulus | 2 | 1979 | 177 | 0.020 |
Why?
|
| Pedigree | 2 | 1982 | 2041 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 7259 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 1527 | 0.020 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1985 | 21 | 0.020 |
Why?
|
| Apoptosis | 2 | 2004 | 7783 | 0.020 |
Why?
|
| Leukemia | 3 | 1984 | 1721 | 0.020 |
Why?
|
| Binding Sites | 2 | 1989 | 2260 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 1990 | 561 | 0.020 |
Why?
|
| Trypsin | 1 | 1985 | 157 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 2324 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 7790 | 0.020 |
Why?
|
| Nose | 1 | 1966 | 140 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1989 | 555 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 1985 | 291 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1966 | 299 | 0.020 |
Why?
|
| Isoantigens | 1 | 1984 | 66 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1985 | 282 | 0.010 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1984 | 18 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1985 | 316 | 0.010 |
Why?
|
| Haploidy | 1 | 1984 | 43 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 2009 | 416 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1984 | 59 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1994 | 13385 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1984 | 99 | 0.010 |
Why?
|
| Biological Factors | 1 | 2004 | 49 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2004 | 151 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1983 | 208 | 0.010 |
Why?
|
| Mollusca | 1 | 1983 | 14 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1992 | 3347 | 0.010 |
Why?
|
| Pneumonia | 1 | 1990 | 798 | 0.010 |
Why?
|
| Methods | 2 | 1981 | 223 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2004 | 353 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 2857 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1989 | 1237 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 33870 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 1982 | 52 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 2033 | 0.010 |
Why?
|
| Chromatography, Agarose | 1 | 1981 | 4 | 0.010 |
Why?
|
| Immunosorbents | 1 | 1981 | 10 | 0.010 |
Why?
|
| Ammonium Sulfate | 1 | 1981 | 13 | 0.010 |
Why?
|
| Carrier Proteins | 2 | 1988 | 2120 | 0.010 |
Why?
|
| Goats | 1 | 1981 | 70 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1985 | 889 | 0.010 |
Why?
|
| Sepharose | 1 | 1981 | 35 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1984 | 424 | 0.010 |
Why?
|
| Immunization | 1 | 1983 | 400 | 0.010 |
Why?
|
| Neoplasms | 2 | 1979 | 15903 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1985 | 1182 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 2 | 1992 | 55 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1966 | 1495 | 0.010 |
Why?
|
| Rats | 2 | 2004 | 6595 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1984 | 1248 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1982 | 274 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 2001 | 87 | 0.010 |
Why?
|
| Iodine Isotopes | 4 | 1973 | 11 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1982 | 487 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1984 | 1655 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 31066 | 0.010 |
Why?
|
| Gingivitis | 1 | 1979 | 6 | 0.010 |
Why?
|
| Periodontitis | 1 | 1979 | 16 | 0.010 |
Why?
|
| Aluminum Silicates | 2 | 1970 | 16 | 0.010 |
Why?
|
| Transplantation, Homologous | 5 | 1974 | 3056 | 0.010 |
Why?
|
| Solubility | 2 | 1977 | 248 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 2248 | 0.010 |
Why?
|
| Mice | 3 | 2019 | 35697 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1980 | 357 | 0.010 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1998 | 72 | 0.010 |
Why?
|
| Blood | 1 | 1979 | 172 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1998 | 152 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 3 | 1967 | 121 | 0.010 |
Why?
|
| Nasal Mucosa | 3 | 1967 | 76 | 0.010 |
Why?
|
| Osteopontin | 1 | 1998 | 146 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 5086 | 0.010 |
Why?
|
| CD5 Antigens | 1 | 1998 | 130 | 0.010 |
Why?
|
| Histamine Release | 1 | 1997 | 15 | 0.010 |
Why?
|
| Antigens, Neoplasm | 3 | 1973 | 1589 | 0.010 |
Why?
|
| Fetus | 1 | 1982 | 675 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 729 | 0.010 |
Why?
|
| Neutralization Tests | 3 | 1967 | 281 | 0.010 |
Why?
|
| Base Sequence | 2 | 1997 | 5453 | 0.010 |
Why?
|
| Alleles | 1 | 1984 | 2594 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1981 | 654 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1977 | 44 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 1820 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1980 | 665 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1984 | 2033 | 0.010 |
Why?
|
| Mast Cells | 1 | 1998 | 231 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1976 | 57 | 0.010 |
Why?
|
| Cell Membrane | 4 | 1975 | 898 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 15247 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1997 | 113 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 12134 | 0.010 |
Why?
|
| Isoantibodies | 2 | 1974 | 121 | 0.010 |
Why?
|
| Veins | 1 | 1997 | 166 | 0.010 |
Why?
|
| Kidney | 2 | 1975 | 2251 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 1998 | 484 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1979 | 265 | 0.010 |
Why?
|
| Latex Fixation Tests | 1 | 1975 | 10 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1975 | 63 | 0.010 |
Why?
|
| Tears | 2 | 1967 | 166 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1979 | 318 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 2 | 1973 | 289 | 0.010 |
Why?
|
| Acute Disease | 2 | 1984 | 2501 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 39818 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1975 | 202 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 1979 | 690 | 0.010 |
Why?
|
| Immunoassay | 1 | 1975 | 214 | 0.010 |
Why?
|
| Adsorption | 2 | 1971 | 50 | 0.010 |
Why?
|
| Azathioprine | 2 | 1971 | 74 | 0.010 |
Why?
|
| Creatinine | 1 | 1976 | 540 | 0.010 |
Why?
|
| Histocompatibility | 2 | 1971 | 183 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1975 | 622 | 0.010 |
Why?
|
| Immunodiffusion | 3 | 1970 | 30 | 0.010 |
Why?
|
| Cats | 1 | 1993 | 173 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1973 | 79 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1973 | 197 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1973 | 241 | 0.010 |
Why?
|
| Sex Factors | 1 | 1979 | 2199 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1993 | 364 | 0.010 |
Why?
|
| Kidney Transplantation | 3 | 1974 | 788 | 0.010 |
Why?
|
| Heart | 1 | 1998 | 1191 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1992 | 107 | 0.010 |
Why?
|
| Cell Separation | 1 | 1993 | 614 | 0.010 |
Why?
|
| Rodent Diseases | 1 | 1971 | 31 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1977 | 1968 | 0.010 |
Why?
|
| Technetium | 1 | 1991 | 80 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1992 | 307 | 0.010 |
Why?
|
| Chemistry | 2 | 1970 | 85 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1970 | 120 | 0.010 |
Why?
|
| Lymphoma | 2 | 1977 | 1524 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1970 | 74 | 0.010 |
Why?
|
| Malaria | 1 | 1971 | 92 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1970 | 138 | 0.010 |
Why?
|
| Biological Transport | 1 | 1992 | 637 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1991 | 657 | 0.010 |
Why?
|
| Models, Biological | 1 | 1998 | 3207 | 0.010 |
Why?
|
| Orthomyxoviridae | 2 | 1967 | 62 | 0.010 |
Why?
|
| Plasmids | 1 | 1992 | 939 | 0.010 |
Why?
|
| Muscles | 1 | 1971 | 460 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 706 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1992 | 764 | 0.010 |
Why?
|
| Tritium | 3 | 1974 | 266 | 0.010 |
Why?
|
| Thymidine | 3 | 1974 | 167 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 1982 | 85 | 0.000 |
Why?
|
| Body Weight | 1 | 1973 | 1323 | 0.000 |
Why?
|
| Recurrence | 1 | 1977 | 4882 | 0.000 |
Why?
|
| Homeostasis | 1 | 1993 | 933 | 0.000 |
Why?
|
| Virus Replication | 1 | 1992 | 772 | 0.000 |
Why?
|
| Bleomycin | 1 | 1989 | 482 | 0.000 |
Why?
|
| Lung Neoplasms | 4 | 1982 | 12032 | 0.000 |
Why?
|
| Kaolin | 1 | 1967 | 4 | 0.000 |
Why?
|
| Biopsy | 1 | 1975 | 3537 | 0.000 |
Why?
|
| Reoviridae | 1 | 1967 | 41 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1993 | 1583 | 0.000 |
Why?
|
| Haplorhini | 1 | 1967 | 152 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1989 | 16646 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1997 | 6436 | 0.000 |
Why?
|
| Cross Reactions | 2 | 1982 | 263 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 3 | 1970 | 89 | 0.000 |
Why?
|
| Muramidase | 1 | 1966 | 115 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1992 | 1727 | 0.000 |
Why?
|
| Cyclophosphamide | 2 | 1971 | 3244 | 0.000 |
Why?
|
| Respiratory Tract Infections | 1 | 1970 | 408 | 0.000 |
Why?
|
| Lipoproteins | 1 | 1967 | 229 | 0.000 |
Why?
|
| Saliva | 1 | 1966 | 238 | 0.000 |
Why?
|
| Albumins | 1 | 1966 | 266 | 0.000 |
Why?
|
| Glioma | 1 | 1976 | 1973 | 0.000 |
Why?
|
| Lipopolysaccharides | 1 | 1967 | 591 | 0.000 |
Why?
|
| Fluorouracil | 1 | 1989 | 1989 | 0.000 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1984 | 58 | 0.000 |
Why?
|
| Breast Neoplasms | 3 | 1982 | 16221 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1976 | 2287 | 0.000 |
Why?
|
| Pancreas | 1 | 1968 | 745 | 0.000 |
Why?
|
| Liver | 2 | 1975 | 3086 | 0.000 |
Why?
|
| Lectins | 2 | 1973 | 152 | 0.000 |
Why?
|
| Lymph Nodes | 2 | 1975 | 3079 | 0.000 |
Why?
|
| Cisplatin | 1 | 1989 | 2501 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1967 | 1309 | 0.000 |
Why?
|
| Cattle | 1 | 1982 | 843 | 0.000 |
Why?
|
| Sheep | 2 | 1970 | 273 | 0.000 |
Why?
|
| Influenza, Human | 1 | 1967 | 762 | 0.000 |
Why?
|
| Erythrocytes | 2 | 1971 | 336 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1984 | 2439 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1973 | 7262 | 0.000 |
Why?
|
| Methylmannosides | 1 | 1975 | 3 | 0.000 |
Why?
|
| Chromium Radioisotopes | 1 | 1975 | 8 | 0.000 |
Why?
|
| Whole-Body Counting | 1 | 1975 | 25 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1975 | 387 | 0.000 |
Why?
|
| Twins | 1 | 1973 | 78 | 0.000 |
Why?
|
| Serotyping | 1 | 1973 | 192 | 0.000 |
Why?
|
| Eggs | 1 | 1973 | 26 | 0.000 |
Why?
|
| ABO Blood-Group System | 1 | 1973 | 125 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1973 | 125 | 0.000 |
Why?
|
| Skin Tests | 1 | 1973 | 102 | 0.000 |
Why?
|
| Antibody-Producing Cells | 1 | 1971 | 20 | 0.000 |
Why?
|
| Quinacrine | 1 | 1971 | 5 | 0.000 |
Why?
|
| Plasmodium | 1 | 1971 | 8 | 0.000 |
Why?
|
| Streptolysins | 1 | 1971 | 14 | 0.000 |
Why?
|
| Autoradiography | 1 | 1971 | 158 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1971 | 148 | 0.000 |
Why?
|
| Bence Jones Protein | 1 | 1970 | 11 | 0.000 |
Why?
|
| Thiocyanates | 1 | 1970 | 18 | 0.000 |
Why?
|
| Coxsackievirus Infections | 1 | 1970 | 11 | 0.000 |
Why?
|
| Horses | 1 | 1970 | 99 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1970 | 28 | 0.000 |
Why?
|
| Tannins | 1 | 1970 | 6 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1970 | 27 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1975 | 2462 | 0.000 |
Why?
|
| Aluminum | 1 | 1970 | 19 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1970 | 249 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1973 | 606 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1970 | 463 | 0.000 |
Why?
|
| Immunity | 1 | 1971 | 356 | 0.000 |
Why?
|
| Hemadsorption Inhibition Tests | 1 | 1967 | 1 | 0.000 |
Why?
|
| Absorption | 1 | 1967 | 80 | 0.000 |
Why?
|
| Manganese | 1 | 1967 | 65 | 0.000 |
Why?
|
| Chlorides | 1 | 1967 | 139 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1971 | 865 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1971 | 1847 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1976 | 5315 | 0.000 |
Why?
|
| Heparin | 1 | 1967 | 342 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1975 | 7121 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1970 | 1440 | 0.000 |
Why?
|
| Pregnancy | 1 | 1973 | 8110 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1970 | 5697 | 0.000 |
Why?
|